Evidence mapPaperPMID 18268136Full record

ArticleHypertension (Dallas, Tex. : 1979)2008

Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients.

Piotr Jankowski, Kalina Kawecka-Jaszcz, Danuta Czarnecka, Malgorzata Brzozowska-Kiszka, Katarzyna Styczkiewicz, Magdalena Loster, Małgorzata Kloch-Badełek, Jerzy Wiliński, Adam M Curyło, Dariusz Dudek and 1 more

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 75 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 4 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02887677 phase4terminatedstarted 2016, after this paper: background citation

A Study of the Effects of Dapagliflozin on Ambulatory Aortic Pressure, Arterial Stiffness and Urine Albumin Excretion in Patients With Type 2 Diabetes

Ran2016Enrolled85Registered outcomes9Posted comparisons0ConditionsDiabetes MellitusArmsdapagliflozin, Placebo
Open the trial in the graph
NCT02403349 phase4unknown statusnot on this mapstarted 2012, after this paper: background citation

Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol

TypeinterventionalSponsorAjou University School of MedicineRan2012 to 2015Enrolled105ConditionsBlood Pressure, Ischemic StrokeArmsFimasartan, Valsartan, Atenolol
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. I Luso-Brazilian Positioning on Central Arterial Pressure.Arquivos brasileiros de cardiologia · 2017
    Guideline
  3. Guideline
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Integrative physiological assessment of cerebral hemodynamics and metabolism in acute ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Review
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Piotr JankowskiI Department of Cardiology and Hypertension, Collegium Medicum Jagiellonian University, Kraków, Poland. piotrjankowski@interia.pl
Kalina Kawecka-Jaszcz
Danuta Czarnecka
Malgorzata Brzozowska-Kiszka
Katarzyna Styczkiewicz
Magdalena Loster
Małgorzata Kloch-Badełek
Jerzy Wiliński
Adam M Curyło
Dariusz Dudek
Aortic Blood Pressure and Survival Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the differences between central and peripheral blood pressure (BP) values have been known for decades, the consequences of decision making based on peripheral rather than central BP have only recently been recognized. There are only a few studies assessing the relationship between intraaortic BP and cardiovascular risk. In addition, the relationship between central BP and the risk of cardiovascular events in a large group of coronary patients has not yet been evaluated. Therefore, the aim of the study was to determine the prognostic significance of central BP-derived indices in patients undergoing coronary angiography. Invasive central BPs were taken at baseline, and study end points were ascertained during over a 4.5-year follow-up in 1109 consecutive patients. The primary end point (cardiovascular death or myocardial infarction or stroke or cardiac arrest or heart transplantation or myocardial revascularization) occurred in 246 (22.2%) patients. Central pulsatility was the most powerful predictor of the primary end point (hazard ratio [HR] 1.30, 95% confidence interval [CI] 1.14 to 1.48). Central pulse pressure was also independently related to the primary end point (HR 1.25, 95% CI 1.09 to 1.43). Central mean BP as well as peripheral BP parameters were not independently related to the primary end point risk. Central pulsatility was also related to risk of cardiovascular death or myocardial infarction or stroke. The pulsatile component of BP is the most important factor related to the cardiovascular risk in coronary patients. It is more closely associated with cardiovascular risk than steady component of BP.

Indexed as

AgedAortaBlood PressureBrachial ArteryCoronary AngiographyCoronary Artery DiseaseFemaleHumansHypertensionMaleMiddle AgedPredictive Value of TestsPrognosisProportional Hazards ModelsPulsatile FlowRisk Factors

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.